ArticleFrontiers in oncology2023

Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors.

Andrea Cavazzoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.